---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-000722"
form_type: "8-K"
ticker: "PTHS"
cik: "0001919246"
company_name: "Pelthos Therapeutics Inc."
filed_at: "2025-05-01T23:59:59+00:00"
generated_at: "2026-05-23T01:12:24.251147+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "medium"
source: SEC EDGAR
---

# Channel Therapeutics issues NYSE American-required announcement on going concern in 2024 10-K

## Summary
- 2024 10-K audit opinion includes a going concern emphasis of matter (previously filed March 27, 2025).
- Press release issued May 1, 2025 to comply with NYSE American Sections 401(h) and 610(b).
- Announcement does not change or amend the audited financial statements or the 2024 10-K.
- Company develops non-opioid pain therapeutics (no new business updates).

## SEC filing metadata
- accession: 0001753926-25-000722
- form_type: 8-K
- ticker: PTHS
- cik: 0001919246
- company_name: Pelthos Therapeutics Inc.
- filed_at: 2025-05-01T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000175392625000722/0001753926-25-000722-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1919246/000175392625000722/g084795_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-000722
- JSON: https://secwatch.observer/filing/0001753926-25-000722.json
- Plain text: https://secwatch.observer/filing/0001753926-25-000722.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.